MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially nominated him to represent the company on the board, but appears to have changed its stance. In response to the shareholders’ concerns, the General Authority for Freezones and Investment restricted Hegazy from becoming a member on the board of any other companies, prompting him to step down from his position. October Pharma has not yet chosen who will replace the former chairman.
More from Enterprise
CIB says it received the green light to start due diligence on HSBC Egypt’s retail franchise
CIB is not the only potential suitor for HSBC’s retail…
EGX kicks off first day of futures trading on the EGX
The rollout includes 3- and 6-month future contracts tracking the…
Under-construction data centers tap ratings to fund AI buildup
Developers are securing investment-grade ratings to unlock new pools of…
Bahrain’s Beban eyes Egypt launch with equity crowdfunding model
Mohamed Aboulnaga’s Foras AI raises stake as Beban seeks FRA…